Insider · CIK 0001831410

Harmon Cyrus

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001831410

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-24	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−12.5K sh	$11.71	−$146K	702,770
2026-07-23	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−12.5K sh	$11.58	−$145K	715,270
2026-06-18	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.5K sh	—	—	29,500
2026-01-20	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−10K sh	$26.88	−$269K	727,770
2026-01-14	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−3,489 sh	$29.12	−$102K	737,770
2025-12-22	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−2,881 sh	$28.53	−$82.2K	741,259
2025-09-18	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−10K sh	$8.33	−$83.3K	744,140
2025-09-18	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−3,086 sh	$8.32	−$25.7K	117,028
2025-09-16	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−10K sh	$8.04	−$80.4K	754,140
2025-09-16	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−1,914 sh	$8.08	−$15.5K	120,114
2025-06-11	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.2K sh	—	—	24,150
2024-12-11	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−7,958 sh	$8.66	−$68.9K	764,319
2024-12-11	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−179 sh	$9.39	−$1,680.81	764,140
2024-12-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−8,256 sh	$9.37	−$77.4K	772,277
2024-12-09	OLMAOlema Pharmaceuticals, Inc.A Award	Director	AAward	+29.3K sh	—	—	780,533
2024-07-30	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−934 sh	$15.55	−$14.5K	751,283
2024-07-29	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−4,066 sh	$15.58	−$63.3K	752,217
2024-07-11	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$12.26	−$61.3K	756,283
2024-06-28	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−20K sh	$10.77	−$215K	761,283
2024-06-14	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2024-06-04	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$12.33	−$61.7K	781,283
2024-06-03	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$10.93	−$54.7K	786,283
2024-05-31	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−15K sh	$9.41	−$141K	791,283
2024-05-06	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$10.92	−$54.6K	806,283
2024-04-30	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−15K sh	$9.51	−$143K	811,283
2024-03-28	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−20K sh	$10.97	−$219K	826,283
2024-02-29	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−24.9K sh	$12.41	−$309K	846,383
2024-02-29	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−100 sh	$13.00	−$1,300	846,283
2024-02-01	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$15.56	−$77.8K	871,283
2024-01-31	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−25K sh	$12.23	−$306K	876,283
2023-12-29	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−22.5K sh	$13.30	−$299K	903,783
2023-12-29	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−2,500 sh	$14.10	−$35.3K	901,283
2023-11-30	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−25K sh	$12.57	−$314K	926,283
2023-11-22	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−3,989 sh	$13.90	−$55.4K	951,283
2023-11-21	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−4,192 sh	$14.86	−$62.3K	955,272
2023-11-20	OLMAOlema Pharmaceuticals, Inc.A Award	Director	AAward	+15.8K sh	—	—	959,464
2023-11-02	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$15.64	−$78.2K	943,714
2023-10-31	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−25K sh	$12.05	−$301K	948,714
2023-09-29	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−25K sh	$12.41	−$310K	973,714
2023-09-05	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−10K sh	$11.62	−$116K	998,714
2023-08-31	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−15K sh	$9.36	−$140K	1,008,714
2023-08-16	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−15K sh	$10.14	−$152K	1,023,714
2023-08-16	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−15K sh	$10.14	−$152K	1,023,714
2023-06-08	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−10K sh	$6.30	−$63K	1,038,714
2023-06-06	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$6.29	−$31.5K	1,048,714
2023-06-05	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$6.04	−$30.2K	1,053,714
2023-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+150K sh	—	—	150,000
2022-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+105K sh	—	—	104,500
2021-11-29	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−400 sh	$24.76	−$9,904	1,051,146
2021-10-19	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−7,445 sh	$27.85	−$207K	1,056,101

Recent filings

Accepted (ET)
Jul 274
Harmon Cyrus0001831410-26-000008
SEC(opens sec.gov)
Jun 234
Harmon Cyrus0001831410-26-000006
SEC(opens sec.gov)
Jan 214
Harmon Cyrus0001831410-26-000004
SEC(opens sec.gov)
Jan 164
Harmon Cyrus0001831410-26-000002
SEC(opens sec.gov)
Dec 294
Harmon Cyrus0001831410-25-000007
SEC(opens sec.gov)
Sep 184
Harmon Cyrus0001831410-25-000004
SEC(opens sec.gov)
Jun 134
Harmon Cyrus0001415889-25-017234
SEC(opens sec.gov)
Dec 114
Harmon Cyrus0001415889-24-029028
SEC(opens sec.gov)
Jul 314
Harmon Cyrus0001415889-24-020461
SEC(opens sec.gov)
Jul 124
Harmon Cyrus0001415889-24-019528
SEC(opens sec.gov)
Jul 24
Harmon Cyrus0001415889-24-018975
SEC(opens sec.gov)
Jun 184
Harmon Cyrus0001415889-24-017443
SEC(opens sec.gov)

Companies

Olema Pharmaceuticals, Inc.DirectorOLMA

Address

C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST

SAN FRANCISCO, CA, 94103